0001415889-21-001454.txt : 20210311 0001415889-21-001454.hdr.sgml : 20210311 20210311192317 ACCESSION NUMBER: 0001415889-21-001454 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210309 FILED AS OF DATE: 20210311 DATE AS OF CHANGE: 20210311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cozzens Todd C CENTRAL INDEX KEY: 0001382487 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37478 FILM NUMBER: 21734919 MAIL ADDRESS: STREET 1: ONE FEDERAL STREET STREET 2: 25TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Natera, Inc. CENTRAL INDEX KEY: 0001604821 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 010894487 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 13011 MCCALLEN PASS STREET 2: BUILDING A SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78753 BUSINESS PHONE: 650-249-9090 MAIL ADDRESS: STREET 1: 13011 MCCALLEN PASS STREET 2: BUILDING A SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78753 4 1 form4-03112021_040305.xml X0306 4 2021-03-09 0001604821 Natera, Inc. NTRA 0001382487 Cozzens Todd C C/O NATERA, INC. 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753 true false false false Common Stock 2021-03-09 4 M 0 29475 1.3855 A 36753 D Common Stock 2021-03-09 4 S 0 29475 100.352 D 7278 D Common Stock 2021-03-11 4 M 0 20000 1.3855 A 27278 D Common Stock 2021-03-11 4 S 0 9283 103.378 D 17995 D Common Stock 2021-03-11 4 S 0 10717 103.967 D 7278 D Stock Option (right to buy) 1.3855 2021-03-09 4 M 0 29475 0 D 2023-04-17 Common Stock 29475 51383 D Stock Option (right to buy) 1.3855 2021-03-04 4 M 0 20000 0 D 2023-04-17 Common Stock 20000 31383 D The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.00 to $100.98 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.70 to $103.69 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.71 to $104.17 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The option vests in 48 equal monthly installments beginning on April 21, 2013. /s/ Tami Chen, Attorney-in-Fact 2021-03-11